Study of Ampion for the Treatment of Adult COVID-19 Patients Requiring Oxygen Supplementation
Clinical trial NCT04456452 · COMPLETED
Trial details
- NCT number
- NCT04456452
- Sponsor
- Ampio Pharmaceuticals. Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-27
- Primary completion
- 2020-09-08
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.